3-methylcholanthrene has been researched along with bumetanide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Choi, YM; Jang, SH; Lee, MG; Lee, SH | 1 |
2 other study(ies) available for 3-methylcholanthrene and bumetanide
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics and the pharmacodynamics of bumetanide in rats.
Topics: Animals; Blood Proteins; Bumetanide; Chlorides; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Gastric Mucosa; Kidney; Liver; Male; Methylcholanthrene; Microsomes, Liver; Phenobarbital; Potassium; Protein Binding; Rats; Rats, Inbred Strains; Sodium | 1991 |